apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Ipca MMF-S Tablet

  3. Ipca MMF-S Tablet Substitute

Ipca MMF-S Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

MYCOPHENOLATE SODIUM-360MG

Uses:

<p>Ipca MMF-S Tablet is used to prevent organ rejection in patients who have undergone a kidney, heart, or liver transplant. The detailed uses of Ipca MMF-S Tablet are as follows:</p><ul><li><strong>Prevents organ rejection: </strong>Ipca MMF-S Tablet helps avoid rejection episodes in patients following organ transplantation.</li><li><strong>Used with other medications:</strong> Ipca MMF-S Tablet is commonly administered alongside other immunosuppressants to enhance effectiveness.</li><li><strong>Maintains graft function: </strong>Ipca MMF-S Tablet supports the long-term survival of the transplanted organ by reducing immune activity.</li></ul>

Medicinal Benefits:

  • Ipca MMF-S Tablet contains Mycophenolate mofetil, an immunosuppressant used primarily in organ transplant recipients.
  • It helps the body accept transplanted organs (like the kidney, heart, or liver) by suppressing immune responses.
  • Ipca MMF-S Tablet inhibits the function of white blood cells (T and B lymphocytes), which are responsible for attacking transplanted organs.
  • It enhances the long-term success of organ transplantation.
  • Ipca MMF-S Tablet is often used along with other immunosuppressants like tacrolimus or cyclosporine for optimal effect.
  • Preferred over long-term use of corticosteroids due to fewer chronic side effects.

FAQs

Ipca MMF-S Tablet is used to prevent the body from rejecting a transplanted organ such as a kidney, heart‚ or liver.

Ipca MMF-S Tablet belongs to the group of medications called immunosuppressants. It works by weakening the immune system by inhibiting the production of cells or antibodies that attack foreign cells. This effect helps in stopping the immune system from targeting and rejecting the transplanted organ.

Ipca MMF-S Tablet causes leukopenia (decreased number of white blood cells) and hence may make you more susceptible to infections. Consult your doctor if you develop any signs of infection, such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising.

Diarrhoea might be a side-effect of Ipca MMF-S Tablet . Drink lots of fluids and eat food rich in fibre if you experience diarrhoea. If you find blood in stools (tarry stools) or if you experience prolonged diarrhoea, consult your doctor. Do not take anti-diarrheal medicine on your own.

Ipca MMF-S Tablet can suppress the immune system and can increase the risk of skin cancer. So, it would be best if you avoid prolonged exposure to sunlight. Also, wear protective clothing covering your head, neck, arms and legs, and use a sunscreen lotion with a high SPF (sun protection factor).

Ipca MMF-S Tablet can suppress the immune system. You should not donate blood while using Ipca MMF-S Tablet and for at least 60 days after stopping treatment, as it makes you more prone to infections. Besides, men should not donate sperm while using Ipca MMF-S Tablet for at least 90 days after stopping the treatment.

Some medicines might absorb mycophenolate sodium more slowly or faster if taken concomitantly, such as antacids containing aluminium or magnesium, colestipol, cholestyramine, or calcium-free phosphate binders. Before taking Ipca MMF-S Tablet , speak with your doctor about your ongoing medication list. Your doctor will decide whether they should be taken along with Ipca MMF-S Tablet .

The live vaccine may not work while on treatment with Ipca MMF-S Tablet . Do not have immunisations/vaccinations without talking to your doctor first. Also, avoid contact with people who have recently had immunisations/vaccinations.

Ipca MMF-S Tablet may cause side effects such as diarrhoea, cough, muscle pain, low blood pressure, fever and respiratory infections. Talk to your doctor if you experience these side effects persistently.

Ipca MMF-S Tablet should be swallowed as a whole with water; do not crush or chew it. Ipca MMF-S Tablet should be taken on an empty stomach (1 hour before or 2 hours after eating or drinking) or as advised by the doctor.

Avoid prolonged or unnecessary exposure to sunlight (sunlamps, tanning beds) and light therapy and wear protective clothing, sunscreen, and sunglasses. This will help lower your risk of developing skin cancer.

Your doctor has prescribed Ipca MMF-S Tablet to suppress the immunity and prevent the rejection of the transplanted kidney.

Ipca MMF-S Tablet may increase the risk of skin cancer as it reduces the body’s defences. Limit the amount of sunlight and UV light, wear protective clothing and use sunscreen with high SPF.

Ipca MMF-S Tablet is not a steroid or chemotherapy medicine. It is an immunosuppressant used to prevent organ rejection after a transplant.

Ipca MMF-S Tablet may cause skin problems such as hair loss. Talk to the doctor if you have any concerns.

The doctor may recommend regular blood tests to check for signs of infection and to monitor the blood count. Women of childbearing potential must provide a negative pregnancy test before the start of treatment.

As Ipca MMF-S Tablet reduces the body’s defences, you may be at a higher risk of developing infections. Therefore, your doctor has asked you to stay away from a person who has chickenpox or shingles.

Ipca MMF-S Tablet causes a high frequency of miscarriage and birth defects. Therefore, before the start of treatment, women of childbearing potential must provide a negative pregnancy test. Also, women who can become pregnant should use effective contraception during treatment and for 6 months after stopping Ipca MMF-S Tablet . Two forms of contraception are preferable as this will reduce the risk of unintended pregnancy. Contact the doctor about the effective methods of contraception.

As a precaution, the male or his female partner must use reliable contraception during treatment and for 90 days after stopping Ipca MMF-S Tablet .

Apollo 247 Floating Button